Locked content Helix BioPharma mulls WSE debut

Helix BioPharma, a Canadian pharmaceutical firm with Polish sharholders, may carry out an IPO on the Warsaw Stock Exchange within the next 12 months, the company’s CEO Robert Verhagen told daily Parkiet. The company is now listed in Toronto and in Frankfurt. “We don’t just want another dual listing....

Locked content Perma Fix Medical plans main market debut in Q1

Perma Fix Medical, a unit of the Perma Fix Environmental Services capital group, would like to debut on the main market of the Warsaw Stock Exchange in Q1 2015, the company’s CEO Louis Centofanti told ISBnews. “We will soon start work on an issue prospectus and a move to the main market of the WSE,”...

Locked content Milestone Medical plans main market IPO

US-based innovative medical devices producer Milestone Medical will soon submit a prospectus to the Polish Financial Supervision Authority, as its plans to move listing from the NewConnect market to the main market of the Warsaw Stock Exchange, the company’s CEO Leonard Osser told ISBnews. “We want ...

Locked content Biomed-Lublin headed for WSE main market

Medical preparations and pharmaceuticals producer Biomed-Lublin plans to move from the NewConnect market to the main market of the Warsaw Stock Exchange. The company said on Friday that it has submitted an issue prospectus to the Financial Supervision Authority. It is not planning a new share issue ...

Locked content Polwax to debut on WSE on Monday

Wax and paraffin producer Polwax will be traded on the main market of the Warsaw Stock Exchange starting from October 6, the bourse said in a recent press release. The company conducted an initial public offering in September, worth PLN 57.3 million. The shares were sold by five shareholders, includ...

Locked content EY to prepare methodology for WSE’s ratings institute

Consultancy EY is preparing the rating criteria and methodology for the Analysis and Ratings Institute of the Warsaw Stock Exchange, according to sources quoted by the Polish Press Agency (PAP). EY was chosen in a procurement procedure, a source close to the matter told PAP. Another source confirmed...

Quo Vadis WSE ?

From one trading session a week to the biggest bourse in the CEE. During nearly 25 years of its existence, the Warsaw Stock Exchange has made paramount progress. But the next few years will be crucial for its future

Locked content Izo-Blok plans main market debut

Plastics producer Izo-Blok plans to debut on the main market of the Warsaw Stock Exchange before the end of this year, the company’s CEO Przemysław Skrzydlak was quoted as saying by the Polish Press Agency. The prospectus is complete and it will soon be sent to the Financial Supervision Authority, S...